title: ALK-positive large B-cell lymphoma with strong CD30 expression; a diagnostic pitfall and resistance to brentuximab and crizotinib.
authors.affiliation: Department of Haematology, King's College Hospital, London, UK.
authors.forename: Varun
authors.initials: V
authors.lastname: Mehra
authors.affiliation: Department of Histopathology, University College Hospital, London, UK.
authors.forename: Sabine
authors.initials: S
authors.lastname: Pomplum
authors.affiliation: Department of Haematology, King's College Hospital, London, UK.
authors.forename: Robin
authors.initials: R
authors.lastname: Ireland
authors.affiliation: Department of Haematology, King's College Hospital, London, UK.
authors.forename: Deborah
authors.initials: D
authors.lastname: Yallop
authors.affiliation: Department of Haematology, King's College Hospital, London, UK.
authors.forename: Stephen
authors.initials: S
authors.lastname: Devereux
authors.affiliation: Department of Haematology, King's College Hospital, London, UK.
authors.forename: Robert
authors.initials: R
authors.lastname: Marcus
authors.affiliation: Department of Histopathology, King's College Hospital, London, UK.
authors.forename: Chirag
authors.initials: C
authors.lastname: Shah
authors.affiliation: Department of Haematology, King's College Hospital, London, UK.
authors.forename: Piers
authors.initials: P
authors.lastname: Patten
authors.affiliation: Department of Haematology, King's College Hospital, London, UK.
authors.forename: Shireen
authors.initials: S
authors.lastname: Kassam
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000079963:Brentuximab Vedotin; D000077547:Crizotinib; D003951:Diagnostic Errors; D019008:Drug Resistance, Neoplasm; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D017404:In Situ Hybridization, Fluorescence; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000175:diagnosis* / Q000188:drug therapy; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D018796:Immunoconjugates; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib; D000079963:Brentuximab Vedotin